as on November 6, 2025 at 2:12 am IST
Day's Low
7.44%
Downside
52 Week's Low
52 Week's High
74.33%
Downside
79.49%
Upside
Check Alterity Therapeutics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$73.0M
EPS (TTM)
-0.82
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-43.23%
Compare market cap, revenue, PE, and other key metrics of Alterity Therapeutics Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $73.0M | -69.43% | NA | -223.35% | |
| BUY | $39.0B | 433.32% | -16.34 | -264.83% | |
| BUY | $57.3B | 207.17% | 1446.9 | 1.36% | |
| BUY | $109.2B | 92.12% | 30.3 | 31.86% | |
| BUY | $67.5B | 6.66% | 15.38 | 32.13% |
The Alterity Therapeutics Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Alterity Therapeutics Ltd investment value today
Current value as on today
₹3,35,860
Returns
₹2,35,860
(+235.86%)
Returns from Alterity Therapeutics Ltd Stock
₹2,30,508 (+230.51%)
Dollar Returns*
₹5,351 (+5.35%)
Search interest for Alterity Therapeutics Ltd Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 802.96K → 3.83M (in $), with an average increase of 54.1% per quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -7.17M → -4.97M (in $), with an average increase of 44.2% per quarter
Best in 1 Year
![]()
In the last 1 year, ATHE has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 904.2% return, outperforming this stock by 900.6%
Price Dip
![]()
In the last 7 days, ATHE stock has moved down by -18.9%
| Organisation | Alterity Therapeutics Ltd |
| Headquarters | 350 Collins Street, Melbourne, VIC, Australia, 3000 |
| Industry | Biotechnology |
| CEO | Dr. David A. Stamler M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Rudolph Emile Tanzi Ph.D. | Chief Scientific Advisor and Member of Research & Development Advisory Board |
Dr. Steven D. Targum M.D. | Chief Medical Advisor |
Dr. Robert Cherny | Head of Research |
Mr. Geoffrey Paul Kempler B.Sc. | Co-Founder & Non-Executive Chairman |
Dr. David A. Stamler M.D. | Chief Executive Officer |
Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A. | CFO & Company Secretary |
Alterity Therapeutics Ltd share price today is $3.9 as on at the close of the market. Alterity Therapeutics Ltd share today touched a day high of $3.9 and a low of $3.61.
Alterity Therapeutics Ltd share touched a 52 week high of $7 on and a 52 week low of $1 on . Alterity Therapeutics Ltd stock price today i.e. is closed at $3.9,which is 44.29% down from its 52 week high and 289.61% up from its 52 week low.
Alterity Therapeutics Ltd market capitalisation is $0.00T as on .
Indian investors can start investing in Alterity Therapeutics Ltd (ATHE) shares with as little as ₹88.615 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.15 in Alterity Therapeutics Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Alterity Therapeutics Ltd share’s latest price of $3.9 as on November 6, 2025 at 2:12 am IST, you will get 2.5641 shares of Alterity Therapeutics Ltd. Learn more about
fractional shares .
Alterity Therapeutics Ltd stock has given -69.43% share price returns and 20.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?